NasdaqCM - Delayed Quote USD

Cytosorbents Corporation (CTSO)

Compare
1.0400
-0.0400
(-3.70%)
At close: January 16 at 4:00:01 PM EST
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-18,493.0530
-21,655.1360
-28,234.2820
-14,005.5990
-5,613.2860
Investing Cash Flow
-681.1590
-936.2360
-6,455.5760
-4,281.2610
-1,676.2180
Financing Cash Flow
21,374.3300
14,474.2100
4,959.6420
715.1990
66,348.3300
End Cash Position
12,246.6240
15,615.0950
23,832.0260
53,825.1660
71,421.6010
Interest Paid Supplemental Data
872.9680
376.6680
--
--
1,127.6470
Capital Expenditure
-681.1590
-936.2360
-6,455.5760
-4,281.2610
-1,676.2180
Issuance of Capital Stock
12,217.3090
14,255.9320
--
--
80,214.0080
Issuance of Debt
15,000.0000
--
5,000.0000
--
1,410.9000
Repayment of Debt
--
--
--
--
-16,410.9000
Repurchase of Capital Stock
--
--
-40.3580
-90.0000
--
Free Cash Flow
-19,174.2120
-22,591.3720
-34,689.8580
-18,286.8600
-7,289.5040
12/31/2020 - 8/8/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers